Bariatric Endoscopy for Treatment of Obesity

Launched by MATER OLBIA HOSPITAL · Apr 17, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at different techniques for a procedure called Endoscopic Gastroplasty (EG) to help people who are struggling with obesity. Specifically, it will compare three different EG methods to see how effective and safe they are for patients with a body mass index (BMI) between 30 and 44.99 kg/m². The trial is taking place at the Gastroenterology and Gastrointestinal Endoscopy Unit in Qatar from June 2020 to August 2024, and they are currently recruiting participants.

To be eligible for the study, participants must be at least 18 years old, have a BMI in the specified range, and have previously tried losing weight through diet without success. They should also be willing to give informed consent and be able to follow the study's guidelines. Participants can expect to undergo one of the EG techniques and will be closely monitored throughout the process for safety and effectiveness. It's important to note that individuals with certain medical conditions or who have had previous bariatric procedures may not qualify for the study. This trial is a unique opportunity to explore new treatments for obesity and may help improve outcomes for those involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age \> 18 years old;
• • acceptance of written informed consent to undergo an EG;
• • capability to understand and comply with the study protocol;
• • obesity: a BMI of 30-34.99 kg/m2 with previous failed attempts at diet and with obesity-related diseases, a BMI of 35-39.99 kg/m2 with previous failed attempts at diet and with or without obesity-related diseases, a BMI of 40-44.99 kg/m2 with previous failed attempts at diet and with or without obesity-related diseases not fit for surgery.
• Exclusion Criteria:
• • patients who do not give their consent to the enrollment in the study or are incompetent, unconscious or unable to express their consent for any reason;
• • patients suffering from any condition which precludes compliance with study instructions;
• • patients who underwent previous attempts at surgical or endoscopic bariatric therapy;
• • patient has any allergy or other known contraindication or intolerance to the medications used in the study;
• • women who are either pregnant or nursing at the time of screening, or are of child-bearing potential and do not practice methods of contraception;
• • patient suffers from a life threatening condition.